- Home
- RMCO vs PRPH Comparison
RMCO vs PRPH Comparison
Compare RMCO & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMCO
- PRPH
- Stock Information
- Founded
- RMCO 2021
- PRPH 1989
- Country
- RMCO United States
- PRPH United States
- Employees
- RMCO N/A
- PRPH N/A
- Industry
- RMCO Multi-Sector Companies
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- RMCO Miscellaneous
- PRPH Health Care
- Exchange
- RMCO Nasdaq
- PRPH Nasdaq
- Market Cap
- RMCO 14.8M
- PRPH 15.5M
- IPO Year
- RMCO N/A
- PRPH 1997
- Fundamental
- Price
- RMCO $1.05
- PRPH $0.70
- Analyst Decision
- RMCO
- PRPH Strong Buy
- Analyst Count
- RMCO 0
- PRPH 1
- Target Price
- RMCO N/A
- PRPH $11.00
- AVG Volume (30 Days)
- RMCO 22.2K
- PRPH 232.3K
- Earning Date
- RMCO 01-24-2025
- PRPH 11-13-2024
- Dividend Yield
- RMCO N/A
- PRPH N/A
- EPS Growth
- RMCO N/A
- PRPH N/A
- EPS
- RMCO N/A
- PRPH N/A
- Revenue
- RMCO $568,896.00
- PRPH $12,753,000.00
- Revenue This Year
- RMCO N/A
- PRPH $36.93
- Revenue Next Year
- RMCO N/A
- PRPH $132.05
- P/E Ratio
- RMCO N/A
- PRPH N/A
- Revenue Growth
- RMCO 21.05
- PRPH N/A
- 52 Week Low
- RMCO $0.70
- PRPH $0.64
- 52 Week High
- RMCO $4.75
- PRPH $7.48
- Technical
- Relative Strength Index (RSI)
- RMCO 52.39
- PRPH 28.79
- Support Level
- RMCO $0.96
- PRPH $0.66
- Resistance Level
- RMCO $1.09
- PRPH $0.74
- Average True Range (ATR)
- RMCO 0.10
- PRPH 0.06
- MACD
- RMCO 0.01
- PRPH 0.05
- Stochastic Oscillator
- RMCO 46.15
- PRPH 34.44
About RMCO Royalty Management Holding Corporation
Royalty Management Holding Corp formed to invest or purchase assets that have current or near-term income to provide the company with accretive cash flow from which it can reinvest in new assets or expand cash flow from existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.